Transitioning from Paper to eSource: Key Considerations
In the last decade, many clinical trial sponsors have shown keen interest in transitioning from paper to e-source to further strengthen the model of decentralized clinical trials. But even a decade later, the adoption has been slow and requires clinical trial organizers to accelerate the process by eliminating the limitations. The good news is that…